Caribbean News Now!

About Us Contact Us

Countries/Territories

Jump to your country or territory of interest

Advertise with us

Reach our daily visitors from around the Caribbean and throughout the world. Click here for rates and placements.

Contribute

Submit news and opinion for publication

Subscribe

Click here to receive our daily regional news headlines by email.

Archives

Click here to browse our extensive archives going back to 2004

Also, for the convenience of our readers and the online community generally, we have reproduced the complete Caribbean Net News archives from 2004 to 2010 here.

Climate Change Watch

The Caribbean is especially vulnerable to rising sea levels brought about by global warming. Read the latest news and information here...

Follow Caribbean News Now on Twitter
Connect with Caribbean News Now on Linkedin
Instagram



News from the Caribbean:






Health
Prev    Next
Cuba to start clinical trials of drug against renal cancer
Published on March 9, 2017Email To Friend    Print Version

heberferon.jpg

HAVANA, Cuba (ACN) -- A clinical trial with Heberferon, one of the leading lines of Cuban biotechnology, will begin this year in Cuba in about 300 patients with renal carcinoma, according to Dr Iraldo Bello, the expert who developed the product at the Center for Genetic Engineering and Biotechnology (CIGB by its Spanish acronym).

Bello said that this formulation, a synergistic combination of recombinant human alpha-2b and gamma interferons, has been applied with good results against basal cell carcinoma, the most frequent skin cancer.

He added that this year they will also conduct a clinical trial with Heberferon in patients with malignant brain tumors.

Preclinical studies and other pilot research in humans show that the results with this product, unique of its kind in the world, can be very promising in these two indications, said the expert.

The CIGB and the National Cancer Control Group develop workshops in which oncologists, pathologists and other specialists participate to educate physicians about the use of the drug, which has already been applied to 800 Cuban patients with basal cell carcinoma.

Bello has spent more than 20 years in the research of this product, which has raised interest in several countries.

Dr Olaine Gray, national coordinator of Special Working Force on Skin Cancer, said that in the past decades skin cancer has increased in the world and is among the first incidences of this malignant disease.

She warned that Cuba reports about 5,000 new cases each year, with an increasing trend.

Skin cancer´s main trigger is the excess of sunlight, specifically ultraviolet radiation, noted the specialist.
 
Reads : 7366






Click here to receive daily news headlines from Caribbean News Now!



Back...

Comments:

No comments on this topic yet. Be the first one to submit a comment.

Back...

Send us your comments!  

Send us your comments on this article. All fields are required.

For your contribution to reach us, you must (a) provide a valid e-mail address and (b) click on the validation link that will be sent to the e-mail address you provide.  If the address is not valid or you don't click on the validation link, it will be a waste of your time typing your submission because we will never see it!

Your Name:

Your Email:

(Validation required)

Comments:
Enter Code *

 


Prev    Next

 

Crestor-induced Type 2 Diabetes

male infertility treatment




Other Headlines:



Regional Sports: